Mobility in Osteogenesis Imperfecta: A Multicenter North American Study

Karen M. Kruger, Angela Caudill, Mercedes Rodriguez Celin, Sandesh C.S. Nagamani, Jay R. Shapiro, Robert D. Steiner, Michael B. Bober, Tracy Hart, David Cuthbertson M.S., Jeff Krischer, Peter H. Byers, Michaela Durigova, Francis H. Glorieux, Frank Rauch, V. Reid Sutton, Brendan Lee, Eric T. Rush, Peter A. Smith, Gerald F. Harris

Research output: Contribution to journalArticlepeer-review


Background Osteogenesis imperfecta (OI) is a genetic connective tissue disorder characterized by increased bone fragility and recurrent fractures. The phenotypic severity of OI has a significant influence on the ability to walk but little is known about the ambulatory characteristics, strength, or functional abilities in individuals with OI, especially in the more severe forms. To advance clinical research in OI, the Linked Clinical Research Centers, network of clinical centers in North America with significant experience in treating patients with OI, was established in 2009. The purpose of this work was to characterize mobility in OI using standard clinical assessment tools. and determine if any patient characteristics could be used to predict mobility outcomes. Methods Data were collected at five clinical sites and included age, gender, ethnicity, height, weight, use of assistive device, and bisphosphonate use and mobility metrics (age at first walk, Gillette Functional Assessment Questionnaire, Functional Mobility Scale, and distance walked in the 6 minute walk test). Linear mixed models were developed to explore the relationships between subject demographics and mobility metrics. Results The study identified 491 individuals age 3 and older. In general, the results showed minor limitations in the type I group while the more severe types showed more significant limitations in all mobility metrics analyzed. Height and weight were shown to be the most significant predictors of mobility metrics. Relationships with mobility and bisphosphonates varied with OI type and whether oral or IV was used. Conclusion This paper is the most comprehensive report of mobility in individuals with OI to date. These results are vital to understanding the mobility limitations of specific types of OI and beneficial when developing rehabilitation protocols for this population. It is important for physicians, patients, and caregivers to gain insight into severity and classification of the disease and the influence of disease-related characteristics on the prognosis for mobility.

Original languageEnglish (US)
JournalUnknown Journal
StatePublished - Jul 27 2018
Externally publishedYes


  • bone
  • gait
  • mobility
  • osteogenesis imperfecta
  • rare disease

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Mobility in Osteogenesis Imperfecta: A Multicenter North American Study'. Together they form a unique fingerprint.

Cite this